Bluetongue serotype 3 (BTV-3) vaccine permits
Permits for certain BTV-3 vaccines.
Defra’s Secretary of State has permitted the use of 3 unauthorised bluetongue serotype 3 (BTV-3) vaccines within the United Kingdom, subject to licence. Available licences to allow use will either be geographically targeted general licences, initially in high risk counties as part of a phased approach, or specific licences which can be applied for through APHA. General licencing will be subject to Risk Assessment.
Unlike some of the authorised BTV vaccines for other BTV serotypes, the vaccine claims for the BTV-3 vaccines include reduction rather than prevention of viraemia. This means that they may not prevent your animals from being infected or infectious, but (depending on the vaccine) their claims include reduction or prevention of clinical signs experienced or mortality.
For this reason, all movement controls and trade restrictions in place will still apply to vaccinated animals.
Contact your private veterinarian if you want to use any of the available BTV-3 vaccines.
Vaccine permits
Summaries of product characteristics (SPCs)
Summaries of product characteristics for bluetongue serotype 3 vaccines in the UK.
Updates to this page
Last updated 4 September 2024 + show all updates
-
Amended second paragraph to clarify the vaccine claims.
-
First published.